Oxytocin for the treatment of drug and alcohol use disorders.

Oxytocin for the treatment of drug and alcohol use disorders.

Item
http://www.wikidata.org/entity/Q38948516
Influence of stress associated with chronic alcohol exposure on drinking.The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish.Compulsive methamphetamine taking in the presence of punishment is associated with increased oxytocin expression in the nucleus accumbens of ratsSubstance use disorders in military veterans: prevalence and treatment challenges.Advances in Pharmacotherapy Development: Human Clinical Studies.Oxytocin Reduces Ethanol Self-Administration in Mice.Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats.Medications for alcohol use disorders: An overview.[Oxytocin and the mechanisms of alcohol dependence].Perception of social interaction compresses subjective duration in an oxytocin-dependent manner.
P2860

Oxytocin for the treatment of drug and alcohol use disorders.

Item
http://www.wikidata.org/entity/Q38948516
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Oxytocin for the treatment of drug and alcohol use disorders.
@en
type
label
Oxytocin for the treatment of drug and alcohol use disorders.
@en
prefLabel
Oxytocin for the treatment of drug and alcohol use disorders.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Oxytocin for the treatment of drug and alcohol use disorders.
@en
P2093
P2860
P304
P31
P356
10.1097/FBP.0000000000000258
P433
P478
P577
P698
P921
P932